Nishiwaki, K., Sugimoto, K., Tamaki, S., Hisatake, J., Yokoyama, H., Igarashi, T., . . . Wakita, H. (2020). Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR(4.5)): The phase 2, multicenter N‐Road study. Cancer Med.
Chicago Style aipamenaNishiwaki, Kaichi, et al. "Optimal Treatment Strategy With Nilotinib for Patients With Newly Diagnosed Chronic‐phase Chronic Myeloid Leukemia Based On Early Achievement of Deep Molecular Response (MR(4.5)): The Phase 2, Multicenter N‐Road Study." Cancer Med 2020.
MLA aipamenaNishiwaki, Kaichi, et al. "Optimal Treatment Strategy With Nilotinib for Patients With Newly Diagnosed Chronic‐phase Chronic Myeloid Leukemia Based On Early Achievement of Deep Molecular Response (MR(4.5)): The Phase 2, Multicenter N‐Road Study." Cancer Med 2020.